{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20241121",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20210428",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "19980529",
          "application_docs": [
            {
              "id": "22431",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/75141ap.pdf",
              "date": "19980529",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "ANDA075141",
      "sponsor_name": "GALT PHARMS",
      "openfda": {
        "application_number": [
          "ANDA075141"
        ],
        "brand_name": [
          "NORGESIC",
          "NORGESIC FORTE",
          "ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE",
          "ORPHENGESIC FORTE"
        ],
        "generic_name": [
          "ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE"
        ],
        "manufacturer_name": [
          "Galt Pharmaceuticals, LLC",
          "Poly Pharmaceuticals, Inc.",
          "Atland Pharmaceuticals, LLC"
        ],
        "product_ndc": [
          "61825-305",
          "50991-999",
          "71993-307",
          "71993-304",
          "61825-302"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ASPIRIN",
          "CAFFEINE",
          "ORPHENADRINE CITRATE"
        ],
        "rxcui": [
          "994528",
          "994530",
          "994535",
          "994537",
          "994539"
        ],
        "spl_id": [
          "47da9e12-c9c2-d80e-e063-6294a90a86aa",
          "472e3862-eab9-2279-e063-6394a90adb4c",
          "415b66fb-2d59-f2f0-e063-6394a90a4318",
          "414d35d9-b9a2-d717-e063-6294a90a9415",
          "414bbb21-3b1f-9924-e063-6294a90a8964"
        ],
        "spl_set_id": [
          "be2761bc-e537-4039-846a-2ffa3d8b2afc",
          "85a3b808-b476-f2f0-e053-2a91aa0af21f",
          "7776aae6-3cbd-4aed-9aac-4bed80339e27",
          "61ca2af1-081c-411c-90ce-ec6d9e3157b2",
          "5bc485db-9d96-4291-aaa3-2a96ebf3098a"
        ],
        "package_ndc": [
          "61825-305-60",
          "50991-999-60",
          "50991-999-06",
          "71993-307-60",
          "71993-304-60",
          "61825-302-60"
        ],
        "nui": [
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832",
          "N0000175739",
          "N0000175729",
          "N0000175790",
          "M0023046"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]",
          "Central Nervous System Stimulation [PE]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]",
          "Xanthines [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]",
          "Central Nervous System Stimulant [EPC]",
          "Methylxanthine [EPC]"
        ],
        "unii": [
          "R16CO5Y76E",
          "3G6A5W338E",
          "X0A40N8I4S"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "ORPHENGESIC",
          "active_ingredients": [
            {
              "name": "ASPIRIN",
              "strength": "385MG"
            },
            {
              "name": "CAFFEINE",
              "strength": "30MG"
            },
            {
              "name": "ORPHENADRINE CITRATE",
              "strength": "25MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "ORPHENGESIC FORTE",
          "active_ingredients": [
            {
              "name": "ASPIRIN",
              "strength": "770MG"
            },
            {
              "name": "CAFFEINE",
              "strength": "60MG"
            },
            {
              "name": "ORPHENADRINE CITRATE",
              "strength": "50MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}